Anticancer Research · 2018 · 10 citations · 16 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyChemotherapyBreast Cancer PharmacotherapyCytotoxic ChemotherapyOncology PharmacologyAnticancer ActivityAnticancer ChemotherapyAnticancer Natural ProductsBreast Cancer ChemotherapyCell Death AssaysCell Viability AssaysMechanism Of Death AnalysisSynthetic Analogues
Background/Aim: In recent years, the search for new anticancer experimental agents derived from natural products or synthetic analogues, such as resorcinolic lipids, has received increased attention. The present study aimed to evaluate the antitumor potential, describe the cell death mechanism and the effects of 3-Heptyl-3,4,6-trimethoxy-3Hisobenzofuran-1-one (AMS35AA) in combination with different chemotherapeutic agents in the MCF-7 cell line. Materials and Methods: Analysis of cytotoxic, genotoxic, membrane integrity, cell death and gene expression induced by the compound was performed. Results: The AMS35AA and its association with 5-FU demonstrated reduction of cell viability; increase of cell death; enhancement of genomic damage and accumulation of cells in G<sub>2</sub>/M phase. Conclusion: AMS35AA has potential for breast cancer treatment since it is capable of exerting cytotoxic and cytostatic effects in a breast cell line and also could be an adjuvant in cancer therapy when combined with 5-FU.
16
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Scott W. Lowe, H. Earl Ruley, Tyler Jacks et al. · Cell · 1993 · 2.9K citations
Cytosporone B is an agonist for nuclear orphan receptor Nur77
Yan-yan Zhan, Xiping Du, Hang‐zi Chen et al. · Nature Chemical Biology · 2008 · 358 citations · Full text
Apoptosis in the absence of caspase 3
Ye Liang, Chaohua Yan, Nina F. Schor · Oncogene · 2001 · 235 citations